M3 acquires Vidal Group

JAPAN – Tokyo-based M3 has bought AXIO Medical Holdings’ global pharmaceutical information data company Vidal Group. 

Healthcare temperature_crop

The Vidal Group has offices in France, Germany and Spain.

M3’s web portal m3.com gives healthcare information to its 250,000 Japanese doctors as well as marketing and R&D support for pharmaceutical companies. Outside Japan, it has more than 3.5 million members and research panel in the US, UK, China, Korea and India.

It first started in 1914 with its pharmaceutical information encyclopaedia and its brands now include Gelbe Liste and MMI Pharmindex in Germany and Vival Vademecum in Spain, Central and South Americas.

M3 said that with this acquisition it intends to maximise the established Vidal brand, physician member base, and pharmaceutical company relationships, while expanding and developing new businesses through its expertise in IT and healthcare.

M3 expects the current management team to remain in place. 

We hope you enjoyed this article.
Research Live is published by MRS.

The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.

Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.

For example, there's an archive of winning case studies from over a decade of MRS Awards.

Find out more about the benefits of joining MRS here.

0 Comments


Display name

Email

Join the discussion

Newsletter
Stay connected with the latest insights and trends...
Sign Up
Latest From MRS

Our latest training courses

Our new 2025 training programme is now launched as part of the development offered within the MRS Global Insight Academy

See all training

Specialist conferences

Our one-day conferences cover topics including CX and UX, Semiotics, B2B, Finance, AI and Leaders' Forums.

See all conferences

MRS reports on AI

MRS has published a three-part series on how generative AI is impacting the research sector, including synthetic respondents and challenges to adoption.

See the reports

Progress faster...
with MRS 
membership

Mentoring

CPD/recognition

Webinars

Codeline

Discounts